These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21763506)

  • 21. NF-IL6 (C/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G.
    Kinoshita SM; Taguchi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15022-7. PubMed ID: 18809921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
    Burri C; Brun R
    Trop Med Parasitol; 1992 Dec; 43(4):223-5. PubMed ID: 1293724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
    Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R
    Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
    Rodgers J; Bradley B; Kennedy PG
    Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [EEG and treatment with Arsobal in human African trypanosomiasis].
    Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
    Guo F; Cen S; Niu M; Saadatmand J; Kleiman L
    J Virol; 2006 Dec; 80(23):11710-22. PubMed ID: 16971427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
    Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
    Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.